Scotland · NHS Scotland MSAN
Tresiba® FlexTouch® (insulin degludec) 100units/ml solution for injection 3ml
MSAN(2025)54 · Level 2 · issued 16 Dec 2025
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| Valid until: product has been discontinued | Discontinued | — |
| 1. Tresiba® FlexTouch® (Insulin degludec) 100units/ml pens have been discontinued. | Discontinued | — |
| Registration for access to the website is available to UK healthcare professionals and | Available | — |
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.